“Yeah. So we really want to have the best impact, I would say. And you don’t have a second chance [to make a good] first impression, as they say.”
Is the German heritage in him coming out in the preparation again? Aduhelm,Lequembi, Aducanumab all had crap for results including mind uou deaths and the Fda has no problem dancing with them on the market stage.
We just need to put together a sound case and we will most likely blow the lid off of what the medical and financial community know about safe, symptomatic treatment for Alzheimer’s.
Lez roll baby!!